… MS-based proteomic biomarker discovery workflow, we measured cerebrospinal fluid (CSF)
proteomes to explore their association with well-established markers of core AD pathology. …

… to study AD disease mechanisms. Here, we review the CSF proteomics literature to identify
… on these proteins to study which biological processes may be involved in the disease. …

… ) of Alzheimer's disease polygenic risk scores for increasing SNP inclusion P-value thresholds,
comparing Alzheimer's disease … of Alzheimer's disease subtypes in Alzheimer's disease …

… A robust proteomic workflow quantifies more than 1,000 proteins in cerebrospinal fluid and
reveals an Alzheimer's Disease-associated signature of more than 20 proteins across three …

… In the present study, plasma proteome profiles of 120 elderly … our proteomic results suggest
that several panels of plasma proteins are relevant to CSF-defined AD and amyloid pathology…

… Here, we compare the proteomes of 34 antemortem CSF samples from AD patients with that
… We characterize the CSF proteomes using 2DE and analyze the resulting quantitative data …

… Here we define AD molecular subtypes using mass spectrometry proteomics in cerebrospinal
fluid, based on 1,058 proteins, with different levels in individuals with AD (n = 419) …

… The aim of this study is to identify the potential cerebrospinal fluid (CSF) biomarkers for
Alzheimer's disease and to evaluate these markers on independent CSF samples using parallel …

… By comparing the CSF proteome between Alzheimer disease (AD) patients and controls it
may be possible to identify proteins that play a role in the disease process and thus to study …

… for monitor of disease progression. In … cerebrospinal fluid proteome of Alzheimer’s disease
patients and non-demented controls to identify potential biomarkers for Alzheimer’s disease. …